Amelie Bonnefond studied agronomy, food-processing, and management (from 2004 to 2007) at Montpellier SupAgro (Montpellier National Superior School of Agronomy, Montpellier, France) where she obtained a diploma of Ingénieur Agronome (5-year higher education degree in Agronomy) in 2007. In parallel, she was graduated in human biology and health at Montpellier II University (France) where she got an M.S. Degree in 2007 with a thesis entitled MYEOV is a new prognostic factor in multiple myeloma (in the INSERM unit U847, Institute of Research in Biotherapy, Montpellier, France). From 2007 to 2010, she prepared a Ph.D. degree in the CNRS unit 8199 (Lille, France) headed by Professor Philippe Froguel, on The genetics of glucose control, under the guidance of Dr. Martine Vaxillaire. She has subsequently been a Postdoctoral Fellow in the same laboratory since January 2012. She is currently the Head of the Next-Generation Sequencing Development and Optimization Group (from capture and massively parallel sequencing to bioinformatics analyses). Her own research is focused on the contribution of rare genetic events to the risk of type 2 diabetes and obesity. In 2011, Amelie was a Postdoctoral Researcher at the EA unit 4373 (Lorraine University, Nancy, France), headed by Dr. Sophie Visvikis-Siest. She worked on the genetics of cellular adhesion molecules and associated quantitative traits, in the post-GWAS era. In 2012, Amelie was a Visiting Postdoctoral Researcher at the INSERM unit 695 (Paris, France), headed by Professor Michel Marre, where she studied the genetics of micro- and macrovascular complications (and related traits) of type 2 diabetes. To date, she has published more than forty articles in peer-reviewed scientific journals including Nature, Nature Genetics, Trends Molecular Medicine, Journal of Biological Chemistry, Diabetes and Diabetologia.
Biography Updated on 11 March 2013